Document is current
Any future updates will be listed below
-
Authors
Beier, Christoph Patrick https://orcid.org/0000-0001-8268-1492
García Rodríguez, Luis A.
Sáez, María E.
Gaist, David
González-Pérez, Antonio
-
Funding
Funding for this research was provided by:
Region of Southern Denmark (17/18517)
- License Information
-
More Information
Article History
Received: 9 March 2018
Accepted: 23 May 2018
First Online: 31 May 2018
Compliance with ethical standards
: We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.
: Dr. Beier has also served as an advisory board member for UCB and EISAI and received speaker honoraries from UCB, EISAI, and the Danish Epilepsy Association and research support from UCB, EISAI, Novartis, and Pfizer. Dr. Gaist reported receiving honoraria from AstraZeneca (Sweden) for participation as a coinvestigator on a research project. Dr. García Rodríguez, Dr. González-Pérez, and Dr. Sáez work at CEIFE, which has received research grants from Bayer Pharma AG (Germany) and AstraZeneca (Sweden). Dr. García Rodríguez has also served as an advisory board member for Bayer Pharma AG (Germany).
